2119 results about "Hydroxylamine Hydrochloride" patented technology

The invention provides a Fenton and Fenton-like system fortifier and a using method thereof, which relate to a water treating fortifier and a using method thereof and overcomes the defects that the pH value of the Fenton and Fenton-like system reaction water body is limited, the adding amount of Fe<2+> is overhigh in the Fenton reaction, and the reaction speed is low in Fenton-like reaction. The fortifier is selected from ascorbic acid, sodium sulfite, lithium sulfite, potassium sulfite, magnesium sulfite, calcium sulfite, hydroxylamine, hydroxyl-ammonium perchlorate, hydroxylamine sulfate, hydrazine, N,N-diethylhydroxylamine, carbohydrazide, ethanolamine, a hydroxylamine solution or N,N,N',N'-tetra substituted phenylenediamines. The using method has the following steps of: adding the Fenton and Fenton-like system fortifier, fortificated chemicals and peroxide into the treated water body; and then, uniformly stirring to react. The fortifier can accelerate the reaction of water treatment and decrease the using amount of the fortificated chemicals.

Compositions containing certain amines and / or quaternary ammonium compounds, hydroxylamine, corrosion inhibitor, organic diluent and optionally water are capable of removing photoresist, photoresist byproducts and residue and etching residues from a substrate.

The present invention is directed to resist and etching residue removing compositions containing at least one nucleophilic amine compound possessing reduction and oxidation potentials, a two-carbon atom linkage alkanolamine compound, and optionally water and / or one or more corrosion inhibitors. The compositions may be substantially free of hydroxylamine, polar organic solvents, water, corrosion inhibitors, or a combination thereof. The compositions are useful in processes for removing resists and etching residue from metal or metal alloy substrates or substrate layers used in micro-circuitry fabrication.

One aspect of the present invention relates to a ribonucleoside substituted with a phosphonamidite group at the 3′-position. In certain embodiments, the phosphonamidite is an alkyl phosphonamidite. Another aspect of the present invention relates to a double-stranded oligonucleotide comprising at least one non-phosphate linkage. Representative non-phosphate linkages include phosphonate, hydroxylamine, hydroxylhydrazinyl, amide, and carbamate linkages. In certain embodiments, the non-phosphate linkage is a phosphonate linkage. In certain embodiments, a non-phosphate linkage occurs in only one strand. In certain embodiments, a non-phosphate linkage occurs in both strands. In certain embodiments, a ligand is bound to one of the oligonucleotide strands comprising the double-stranded oligonucleotide. In certain embodiments, a ligand is bound to both of the oligonucleotide strands comprising the double-stranded oligonucleotide. In certain embodiments, the oligonucleotide strands comprise at least one modified sugar moiety. Another aspect of the present invention relates to a single-stranded oligonucleotide comprising at least one non-phosphate linkage. Representative non-phosphate linkages include phosphonate, hydroxylamine, hydroxylhydrazinyl, amide, and carbamate linkages. In certain embodiments, the non-phosphate linkage is a phosphonate linkage. In certain embodiments, a ligand is bound to the oligonucleotide strand. In certain embodiments, the oligonucleotide comprises at least one modified sugar moiety.